We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

181 hedge funds and large institutions have $5.02B invested in Roivant Sciences in 2023 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more call options, than puts

Call options by funds: $8.47M | Put options by funds: $1.45M

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

48% more capital invested

Capital invested by funds: $3.39B → $5.02B (+$1.63B)

26% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 46

23% more funds holding

Funds holding: 147 → 181 (+34)

4.33% more ownership

Funds ownership: 60.57% → 64.9% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

Holders
181
Holders Change
+34
Holders Change %
+23.13%
% of All Funds
2.84%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
58
Increased
58
Reduced
46
Closed
23
Calls
$8.47M
Puts
$1.45M
Net Calls
+$7.02M
Net Calls Change
+$3.44M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$87.8M
2
BlackRock
BlackRock
New York
+$55.2M
3
PSC
Patient Square Capital
California
+$52M
4
ACA
Avoro Capital Advisors
New York
+$51.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.8M

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$116M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$33.9M
3
RCMNY
Rubric Capital Management (New York)
New York
-$18.5M
4
Goldman Sachs
Goldman Sachs
New York
-$15M
5
Citadel Advisors
Citadel Advisors
Florida
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFBT
176
Parkside Financial Bank & Trust
Missouri
$1.97K – – –
EWA
177
EverSource Wealth Advisors
Alabama
$1.36K +$1.21K +135 New
QCG
178
Quadrant Capital Group
Ohio
$1.32K – – –
S
179
SignatureFD
Georgia
$887 -$2.25K -251 -74%
Allianz Asset Management
180
Allianz Asset Management
Germany
$200 – – –
CF
181
Cantor Fitzgerald
New York
– -$8.06M -1,091,602 Closed
WCM
182
Whitefort Capital Management
New York
– -$6.15M -833,471 Closed
Alyeska Investment Group
183
Alyeska Investment Group
Illinois
– -$5.02M -561,612 Closed
AA
184
ALPS Advisors
Colorado
– -$3.69M -499,683 Closed
AGM
185
Alpine Global Management
New York
– -$2.21M -300,000 Closed
RCMU
186
Rokos Capital Management (UK)
United Kingdom
– -$2.24M -300,000 Closed
MF
187
Magnetar Financial
Illinois
– -$1.11M -150,000 Closed
SCM
188
Segantii Capital Management
Hong Kong
– -$754K -102,170 Closed
AAA
189
Affinity Asset Advisors
New York
– -$738K -100,000 Closed
PP
190
PDT Partners
New York
– -$515K -69,769 Closed
PI
191
PEAK6 Investments
Illinois
– -$494K -66,934 Closed
Squarepoint
192
Squarepoint
New York
– -$400K -54,174 Closed
ECU
193
Eisler Capital (UK)
United Kingdom
– -$66K -45,221 Closed
PFO
194
Pathstone Family Office
New Jersey
– -$284K -38,488 Closed
SC
195
Shay Capital
New York
– -$185K -25,000 Closed
Verition Fund Management
196
Verition Fund Management
Connecticut
– -$118K -15,946 Closed
TC
197
TwinBeech Capital
New York
– -$81K -10,970 Closed
SIM
198
Sandia Investment Management
Massachusetts
– -$73.8K -10,000 Closed
VFA
199
Values First Advisors
Tennessee
– -$48.6K -6,581 Closed
Belvedere Trading
200
Belvedere Trading
Illinois
– -$37.3K -5,054 Closed
5 6 7
8
9

ROIV Hedge Fund Activity: Q2 2023 in Review

181 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2023, worth a combined $5.02B — up 48% from $3.39B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ROIV positions and 23 closed out — a net gain of 35 holders — while 58 added to existing stakes and 46 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $87.8M. The largest seller was Viking Global Investors, cutting an estimated $116M.

  • 181 institutional investors held Roivant Sciences (ROIV) as of Q2 2023, up from 147 in Q1 2023.
  • Funds reported $5.02B of Roivant Sciences stock for Q2 2023, up 48% quarter-over-quarter.
  • 58 funds opened new Roivant Sciences positions in Q2 2023 and 23 closed out, a net change of +35 holders.
  • The largest Roivant Sciences buyer in Q2 2023 was Morgan Stanley, an estimated $87.8M added.
  • The largest Roivant Sciences seller in Q2 2023 was Viking Global Investors, an estimated $116M sold.

Based on aggregated 13F filings for Q2 2023.